Pregnant People-Infant Linked Longitudinal Surveillance
CDC proposes to allocate funds to implement Notice of Funding Opportunity (NOFO) DD23-2303, Mother-Infant Linked Longitudinal Surveillance.
The project period will be four years, with 4 12-month budget periods and an anticipated project start date of September 1, 202 3. The purpose of this NOFO is to conduct mother-infant linked longitudinal surveillance on key exposures and outcomes of public health interest through both a clinic- and health department-based approach.
These approaches collect health information from various sources and/or conduct data linkages, resulting in robust data across multiple years from pregnancy into childhood.
The cooperative agreement intends to sustain, improve, and expand surveillance efforts from clinical sites and health departments related to mother-infant linked longitudinal data to ensure timely reporting of key exposures and outcomes that impact pregnant people and infants, to improve data quality and share evolving outcome data, to innovate clinical strategies, and build a strong collaborative network.
Priority exposures and outcomes of public health interest may include, but not limited to medication for opioid use disorder, neonatal abstinence syndrome, cytomegalovirus, stillbirths (not intended to be longitudinal), and other conditions that may have serious impacts on pregnant people and infants.
Strategic areas of focus may include advancing interoperability, data quality and informatics, and innovating and strengthening public health reporting.
Focus areas may also include monitoring maternal, infant, and child outcomes including follow-up for diverse clinical and neurodevelopmental outcomes of children exposed to infectious and non-infectious threats that are not currently national notifiable.
The project period will be four years, with 4 12-month budget periods and an anticipated project start date of September 1, 202 3. The purpose of this NOFO is to conduct mother-infant linked longitudinal surveillance on key exposures and outcomes of public health interest through both a clinic- and health department-based approach.
These approaches collect health information from various sources and/or conduct data linkages, resulting in robust data across multiple years from pregnancy into childhood.
The cooperative agreement intends to sustain, improve, and expand surveillance efforts from clinical sites and health departments related to mother-infant linked longitudinal data to ensure timely reporting of key exposures and outcomes that impact pregnant people and infants, to improve data quality and share evolving outcome data, to innovate clinical strategies, and build a strong collaborative network.
Priority exposures and outcomes of public health interest may include, but not limited to medication for opioid use disorder, neonatal abstinence syndrome, cytomegalovirus, stillbirths (not intended to be longitudinal), and other conditions that may have serious impacts on pregnant people and infants.
Strategic areas of focus may include advancing interoperability, data quality and informatics, and innovating and strengthening public health reporting.
Focus areas may also include monitoring maternal, infant, and child outcomes including follow-up for diverse clinical and neurodevelopmental outcomes of children exposed to infectious and non-infectious threats that are not currently national notifiable.
Related Programs
Birth Defects and Developmental Disabilities - Prevention and Surveillance
Department of Health and Human Services
Agency: Department of Health and Human Services
Office: Centers for Disease Control - NCBDDD
Estimated Funding: $5,000,000
Office: Centers for Disease Control - NCBDDD
Estimated Funding: $5,000,000
Who's Eligible
Relevant Nonprofit Program Categories
Obtain Full Opportunity Text:
http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-026.html
Additional Information of Eligibility:
Eligible applicants must have the public health authority, legislative mandate or otherwise show legal access to the requisite data to conduct clinic or population-based surveillance.
This authority allows unique and specific access to datasets from multiple data sources that are required to implement the activities outlined in this NOFO.
This may be an MOU, letter of support, or other legal documentation to demonstrate public health authority, legislative mandate, or legal access to the data.
Eligible applicants must document this authority in "Other Attachment Forms" with attachment name "Legal Authority" as a PDF uploaded to www.grants.gov.
CDC will consider any application that does not include this required documentation as non-responsive, and it will receive no further review. A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application.
If applying as a Bona Fide Agent of a state government, a letter from the state government as documentation of the status is required and should be submitted under "Other Attachment Forms" with attachment name "Bona Fide Agent.” If the Bona Fide Agent attachment does not specify legal authority, the applicant must include an attachment named "Legal Authority" in "Other Attachment Forms". The NOFO has three components: A, B, and C.
Eligible applicants may only apply for Component A, Component B, or Component C.
If an applicant submits multiple applications, all applications will be deemed non-responsive, and none will receive further review.
In the “Descriptive Title of Applicant’s Project” on the SF-424 form, applicants must identify the component to which they are applying.
Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-026.html
Contact:
Agency Email Description:
preg_infant_surv@cdc.gov
Agency Email:
Date Posted:
2023-02-09
Application Due Date:
Archive Date:
2023-05-10
Social Entrepreneurship
Spotlight
Keeping Half the Profits Beats Non-profits for Social Impact
Melbourne social enterprise Who Gives A Crap sold nearly 3 million rolls of toilet paper in 2014/15 and gave half the proceeds to WaterAid Australia, but co-founder Simon Griffiths says the donation would have been less had the startup adopted a non-profit model when it launched two years ago.
Learn How to Identify and Avoid Grant Scams
